Leap Therapeutics Inc.

NASDAQ: LPTX · Real-Time Price · USD
0.42
0.03 (6.87%)
At close: Jun 09, 2025, 3:59 PM

Leap Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-67.56M -81.41M -54.6M -40.59M
Depreciation & Amortization
5K 15K 16K 29K
Stock-Based Compensation
5.5M 5.13M 5.18M 3.48M
Other Working Capital
388K 497K -1.6M -2.89M
Other Non-Cash Items
457K 30.01M 855K 527K
Deferred Income Tax
n/a n/a 152K 379K
Change in Working Capital
1.29M 2.51M -651K 1.01M
Operating Cash Flow
-60.3M -43.75M -49.04M -35.16M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a 50.36M n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -1.39M n/a n/a
Investing Cash Flow
n/a 48.97M n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -1K n/a n/a
Dividend Paid
-234K n/a n/a n/a
Other Financial Acitivies
37.42M -1K -210K 813K
Financial Cash Flow
37.18M -30K -210K 98.03M
Net Cash Flow
-23.39M 5.14M -49.42M 62.84M
Free Cash Flow
-60.3M -43.75M -49.04M -35.16M